Michele De Palma PhD

Dr. Michele De Palma obtained his PhD in 2004 at the University of Torino Medical School (Italy), where he developed genetic vectors and transgenic mouse models to study the role of bone marrow-derived cells in tumor angiogenesis with Dr. Luigi Naldini. He then moved to the San Raffaele Scientific Institute in Milan to pursue novel cancer gene therapy strategies and to continue his studies on proangiogenic macrophages. He has been recently appointed Assistant Professor at the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland. His current research interests focus on how macrophages modulate tumor responses to antiangiogenic and cytotoxic therapies.